02126 JW THERAP-B
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 1.74X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 4.0% | Net Margin | N/A |
Total Debt/Equity | 36.1% | Return on Equity | N/A |
Price/Book | 1.28X | Return on Assets | N/A |
(HKD 3.840) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -628.13 | -846.49 | -948.69 | -859.02 | -1,974.60 |
---|---|---|---|---|---|
Net Profit Growth (%) | +25.8 | +10.8 | -10.4 | +56.5 | -178.9 |
Earnings Per Share (HKD) | -1.519 | -2.057 | -2.313 | -2.149 | -14.97 |
Earnings Per Share Growth (%) | +26.2 | +11.1 | -7.7 | +85.7 | +99.9 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 2.992 | 4.500 | 6.422 | 8.374 | 10.493 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 158.218 | 173.856 | -9.0 | 145.702 |
Operating Result | -590.624 | -767.067 | -23.0 | -845.967 |
Profit Before Taxation | -590.624 | -767.996 | -23.1 | -846.135 |
Profit /( Loss) After Taxation | -590.624 | -767.996 | -23.1 | -846.135 |
Net Profit | -590.624 | -767.996 | -23.1 | -846.135 |
Earnings Per Share () | -1.5186 | -2.0569 | -26.2 | -2.3133 |
Announcement Date | 2025-03-27 | 2024-03-20 | NA | 2023-03-29 |
* Annualised
Last Update Time: 2025-07-22 21:40:25